Markus Loeffler Selected Research

Markus Loeffler Research Topics

Disease

33	Neoplasms (Cancer) 02/2022 - 01/2002
16	B-Cell Lymphoma (Lymphoma, B Cell) 02/2022 - 06/2006
13	Lymphoma (Lymphomas) 12/2019 - 08/2004
11	Glioma (Gliomas) 08/2021 - 12/2010
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 03/2006
10	Glioblastoma (Glioblastoma Multiforme) 06/2021 - 12/2009
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019 - 05/2006
7	Sepsis (Septicemia) 11/2021 - 01/2008
7	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2019 - 06/2006
5	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 08/2010
5	Septic Shock (Toxic Shock Syndrome) 11/2021 - 01/2008
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 01/2016
5	Hodgkin Disease (Hodgkin's Disease) 02/2018 - 01/2002
4	Obesity 10/2021 - 01/2018
4	Astrocytoma (Pilocytic Astrocytoma) 08/2021 - 12/2010
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2005
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2005
3	Heart Failure 02/2022 - 12/2005
3	Oligodendroglioma 06/2021 - 12/2007
3	Neutropenia 04/2021 - 01/2009
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 11/2009
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2016 - 09/2008
2	Pneumonia (Pneumonitis) 01/2022 - 12/2020
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 11/2010
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Atrial Fibrillation 12/2019 - 01/2019
2	Breast Neoplasms (Breast Cancer) 02/2018 - 07/2006
2	Vascular Diseases (Vascular Disease) 01/2018 - 07/2015
2	Type 2 Diabetes Mellitus (MODY) 11/2017 - 11/2006
2	Infections 01/2016 - 01/2002
2	Cytopenia 05/2014 - 01/2009
2	Genetic Translocation (Chromosomal Translocation) 04/2014 - 07/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013 - 10/2006

Drug/Important Bio-Agent (IBA)

20	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 01/2002
18	Vincristine (Oncovin)FDA LinkGeneric 02/2022 - 01/2002
18	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 01/2002
15	Prednisone (Sone)FDA LinkGeneric 02/2022 - 01/2002
13	Rituximab (Mabthera)FDA Link 02/2022 - 05/2006
11	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2007
9	Etoposide (VP 16)FDA LinkGeneric 04/2021 - 01/2002
8	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
8	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2021 - 12/2009
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2005
7	Biological ProductsIBA 12/2021 - 06/2006
7	Proteins (Proteins, Gene)FDA Link 03/2013 - 01/2005
6	CytokinesIBA 01/2022 - 07/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2006
5	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2006
4	Calcibiotic Root Canal SealerIBA 01/2020 - 02/2010
4	Insulin (Novolin)FDA Link 01/2019 - 11/2006
3	Phytosterols (Plant Sterols)IBA 10/2022 - 08/2010
3	Prednisolone (Predate)FDA LinkGeneric 04/2021 - 02/2008
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 05/2014
3	Retinaldehyde (Retinal)IBA 01/2021 - 07/2015
3	Bleomycin (Blenoxane)FDA LinkGeneric 08/2007 - 01/2002
3	Dacarbazine (DIC)FDA LinkGeneric 08/2007 - 01/2002
3	Vinblastine (Vinblastine Sulfate)FDA Link 08/2007 - 01/2002
2	pro-brain natriuretic peptide (1-76)IBA 02/2022 - 01/2021
2	LDL CholesterolIBA 01/2022 - 12/2021
2	LipidsIBA 01/2022 - 12/2021
2	Hormones (Hormone)IBA 10/2021 - 11/2019
2	SteroidsIBA 10/2021 - 11/2019
2	MethyltransferasesIBA 01/2021 - 04/2017
2	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2018
2	Troponin T (Troponin T1)IBA 01/2021 - 12/2019
2	O-(6)-methylguanineIBA 01/2021 - 04/2017
2	Complement System Proteins (Complement)IBA 01/2019 - 12/2010
2	ProcalcitoninIBA 03/2018 - 01/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2018 - 01/2009
2	ErbB Receptors (EGF Receptor)IBA 11/2017 - 12/2009
2	epidermal growth factor receptor VIIIIBA 11/2017 - 05/2014
2	MicroRNAs (MicroRNA)IBA 11/2016 - 09/2008
2	Messenger RNA (mRNA)IBA 11/2016 - 01/2009
2	ParaffinIBA 01/2016 - 03/2013
2	Carrier Proteins (Binding Protein)IBA 09/2015 - 11/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2014 - 05/2010
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 10/2013 - 12/2009
2	Alkylating AgentsIBA 10/2013 - 09/2012
2	Tyrosine Kinase InhibitorsIBA 01/2013 - 10/2006
2	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 10/2006
2	N 30IBA 07/2011 - 12/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2010 - 12/2005
2	ChemokinesIBA 05/2009 - 11/2006
2	Methotrexate (Mexate)FDA LinkGeneric 04/2009 - 01/2002
2	VaccinesIBA 07/2006 - 01/2005
2	DNA VaccinesIBA 07/2006 - 06/2005
2	Procarbazine (Matulane)FDA Link 06/2003 - 01/2002
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2022
1	Carvedilol (Coreg)FDA LinkGeneric 01/2022

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 02/2022 - 06/2003
19	Therapeutics 04/2021 - 01/2002
10	Radiotherapy 01/2021 - 01/2002
5	Stem Cell Transplantation 04/2021 - 01/2006
4	Immunotherapy 05/2009 - 01/2005
3	Chemoradiotherapy 08/2021 - 05/2014
2	Hysterectomy 01/2021 - 01/2021
2	Salpingo-oophorectomy 01/2021 - 01/2021
2	Intravenous Administration 01/2016 - 08/2008
2	Transplantation 12/2012 - 01/2006
2	VAP-cyclo protocol 05/2010 - 01/2006